Mandate

Vinge advises H Intressenter in connection with offer for Höganäs

February 14, 2013

FAM (Foundation Asset Management Sweden AB) and Lindéngruppen AB have, through the jointly owned company H Intressenter AB, announced a public offer for all of the shares in Höganäs AB. The offer values Höganäs AB at approximately SEK 11.2 billion.

Höganäs AB is the world’s leading producer of metal powder. The company’s class B shares are listed on NASDAQ OMX Stockholm.

Vinge and Hannes Snellman are advising H Intressenter AB. Vinge’s team is led by responsible partner Göran Nyström and also consists of Charlotte Levin, Jo-Anna Nordström and Oskar Belani as well as Johan Cederblad (environmental), Mikael Ståhl and Marie Brommesson (financing) as well as Johan Karlsson and Peter Alstergren (competition).

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024